Kristi Clark (Tisch MSRCNY) presented the following article in Journal Club. Article Title: Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of b-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis Reference: J.L. Grant, E.E.B. Ghosn, R.C...
Dr. Stephen G. Waxman, MD, PhD, Bridget Marie Flaherty Professor of Neurology and Professor of Neurobiology and of Pharmacology and Director, Center for Neuroscience and Regeneration Research, Yale University School of Medicine, presented a Grand Rounds lecture at the Tisch MS Research Center of...
Forrest Anderson (Tisch MSRCNY) presented the following article in Journal Club. Article Title: Increased CD8+ T cell Response to Epstein-Barr Virus Lytic Antigens in the Active phase of Multiple Sclerosis Reference: D.F. Angelini, B. Serafini, E. Piras, M. Severa, E.M. Coccia, B. Rosicarelli, S...
Congratulations to Dr. Sadiq for his neurology listing in New York Magazine’s 2013 Best Doctor’s Issue ! This is a great achievement and acknowledgement of the hard work and dedication that happens on a daily basis at the IMSMP and Tisch MS Research Center of New York!
On Wednesday, June 12, 2013, Dr. Saud A. Sadiq and Dr. Violaine Harris met with a congressional supporter of our stem cell program. Following this discussion, The Tisch MS Research Center of New York submitted additional information to the FDA on June 18, 2013 and requested a formal meeting with...
Tamara Vyshkina (Tisch MSRCNY) presented the following article in Journal Club. Article Title: Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis Reference: M.A. Rocca, MD, P. Valsasina, MSc, V. Martinelli, MD, P. Misci, MSc, A. Falini, MD, G. Comi, MD, and M...
Violaine Harris (Tisch MSRCNY) presented the following article in Journal Club. Article Title: A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis Reference: S.D. Shields, PhD, X. Cheng, PhD, A. Gasser, PhD, C.Y. Saab, PhD, L. Tyrrell, MS, E.M. Eastman, BS, M...
Tisch MS Research Center of New York has formally submitted a response to the Food and Drug Administration’s (FDA) clinical hold on our proposed Phase I trial of Mesenchymal Stem Cell-Derived Neural Progenitors in the treatment of multiple sclerosis. Per agency rules, this submission necessitates a...
A Research team lead by Violaine Harris, Ph.D., at the Tisch MS Research Center of New York, has just published findings on a new method of measuring disease activity in patients with multiple sclerosis (MS) (Harris, et al, Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis,...